Abstract
Fifty-four college women with symptoms of lower urinary tract infections were randomly treated, 25 with 500 mg of ceftriaxone in a single intramuscular dose and 29 with 160 mg of trimethoprim-800 mg of sulfamethoxazole orally twice daily for 7 days. At 1 week after treatment, 23 patients (92%) in the ceftriaxone group and 28 patients (96%) in the trimethoprim-sulfamethoxazole group were cured. Responses of the patients with positive or negative antibody-coated bacteria tests were not significantly different. Four patients (16%) in the ceftriaxone group developed diarrhea and malaise. One patient (4%) in the trimethoprim-sulfamethoxazole group had medication discontinued because of headaches. Leukopenia was found in one patient (4%) in the ceftriaxone group and four patients (14%) in the trimethoprim-sulfamethoxazole group.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Asmar B. I., Maqbool S., Dajani A. S. Hematologic abnormalities after oral trimethoprim-sulfamethoxazole therapy in children. Am J Dis Child. 1981 Dec;135(12):1100–1103. doi: 10.1001/archpedi.1981.02130360008004. [DOI] [PubMed] [Google Scholar]
- Bailey R. R., Abbott G. D. Treatment of urinary tract infection with a single dose of trimethoprim-sulfamethoxazole. Can Med Assoc J. 1978 Mar 4;118(5):551–552. [PMC free article] [PubMed] [Google Scholar]
- Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
- Bittner M. J., Dworzack D. L., Preheim L. C., Tofte R. W., Crossley K. B. Ceftriaxone therapy of serious bacterial infections in adults. Antimicrob Agents Chemother. 1983 Feb;23(2):261–266. doi: 10.1128/aac.23.2.261. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brumfitt W., Faiers M. C., Franklin I. N. The treatment of urinary infection by means of a single dose of cephaloridine. Postgrad Med J. 1970 Oct;(Suppl):65–69. [PubMed] [Google Scholar]
- CUTLER S. J., EDERER F. Maximum utilization of the life table method in analyzing survival. J Chronic Dis. 1958 Dec;8(6):699–712. doi: 10.1016/0021-9681(58)90126-7. [DOI] [PubMed] [Google Scholar]
- Chadwick E. G., Connor E. M., Shulman S. T., Yogev R. Efficacy of ceftriaxone in treatment of serious childhood infections. J Pediatr. 1983 Jul;103(1):141–145. doi: 10.1016/s0022-3476(83)80802-6. [DOI] [PubMed] [Google Scholar]
- Chadwick E. G., Yogev R., Shulman S. T., Weinfeld R. E., Patel I. H. Single-dose ceftriaxone pharmacokinetics in pediatric patients with central nervous system infections. J Pediatr. 1983 Jan;102(1):134–137. doi: 10.1016/s0022-3476(83)80311-4. [DOI] [PubMed] [Google Scholar]
- Epstein J. S., Hasselquist S. M., Simon G. L. Efficacy of ceftriaxone in serious bacterial infections. Antimicrob Agents Chemother. 1982 Mar;21(3):402–406. doi: 10.1128/aac.21.3.402. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Eron L. J., Park C. H., Hixon D. L., Goldenberg R. I., Poretz D. M. Ceftriaxone therapy of bone and soft tissue infections in hospital and outpatient settings. Antimicrob Agents Chemother. 1983 May;23(5):731–737. doi: 10.1128/aac.23.5.731. [DOI] [PMC free article] [PubMed] [Google Scholar]
- FREEMAN G. H., HALTON J. H. Note on an exact treatment of contingency, goodness of fit and other problems of significance. Biometrika. 1951 Jun;38(1-2):141–149. [PubMed] [Google Scholar]
- Fairley K. F., Bond A. G., Brown R. B., Habersberger P. Simple test to determine the site of urinary-tract infection. Lancet. 1967 Aug 26;2(7513):427–428. doi: 10.1016/s0140-6736(67)90849-5. [DOI] [PubMed] [Google Scholar]
- Fairley K. F., Whitworth J. A., Kincaid-Smith P., Durman O. Single-dose therapy in management of urinary tract infection. Med J Aust. 1978 Jul 15;2(2):75–76. doi: 10.5694/j.1326-5377.1978.tb131369.x. [DOI] [PubMed] [Google Scholar]
- Greenberg R. N., Sanders C. V., Lewis A. C., Marier R. L. Single-dose cefaclor therapy of urinary tract infection. Evaluation of antibody-coated bacteria test and C-reactive protein assay as predictors of cure. Am J Med. 1981 Nov;71(5):841–845. doi: 10.1016/0002-9343(81)90377-6. [DOI] [PubMed] [Google Scholar]
- Iravani A., Pryor N., Richard G. A. Treatment of acute uncomplicated urinary tract infections by cephalexin, with special reference to the antibody-coated bacteria. Int J Clin Pharmacol Ther Toxicol. 1982 Mar;20(3):97–100. [PubMed] [Google Scholar]
- Iravani A., Richard G. A., Baer H., Fennell R. Comparative efficacy and safety of nalidixic acid versus trimethoprim/sulfamethoxazole in treatment of acute urinary tract infections in college-age women. Antimicrob Agents Chemother. 1981 Apr;19(4):598–604. doi: 10.1128/aac.19.4.598. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jordan P. A., Iravani A., Richard G. A., Baer H. Urinary tract infection caused by Staphylococcus saprophyticus. J Infect Dis. 1980 Oct;142(4):510–515. doi: 10.1093/infdis/142.4.510. [DOI] [PubMed] [Google Scholar]
- Judson F. N., Ehret J. M., Root C. J. Comparative study of ceftriaxone and aqueous procaine penicillin G in the treatment of uncomplicated gonorrhea in women. Antimicrob Agents Chemother. 1983 Feb;23(2):218–220. doi: 10.1128/aac.23.2.218. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Knothe H. The effect of a combined preparation of trimethoprim and sulphamethoxazole following short-term and long-term administration on the flora of the human gut. Chemotherapy. 1973;18(5):285–296. doi: 10.1159/000221273. [DOI] [PubMed] [Google Scholar]
- Neu H. C., Meropol N. J., Fu K. P. Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin. Antimicrob Agents Chemother. 1981 Mar;19(3):414–423. doi: 10.1128/aac.19.3.414. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Orskov I., Orskov F., Jann B., Jann K. Serology, chemistry, and genetics of O and K antigens of Escherichia coli. Bacteriol Rev. 1977 Sep;41(3):667–710. doi: 10.1128/br.41.3.667-710.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pontzer R. E., Krieger R. E., Boscia J. A., McNamee W., Levison M. E., Kaye D. Single-dose cefonicid therapy for urinary tract infections. Antimicrob Agents Chemother. 1983 Jun;23(6):814–816. doi: 10.1128/aac.23.6.814. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ronald A. R., Boutros P., Mourtada H. Bacteriuria localization and response to single-dose therapy in women. JAMA. 1976 Apr 26;235(17):1854–1856. [PubMed] [Google Scholar]
- Schaad U. B., Stoeckel K. Single-dose pharmacokinetics of ceftriaxone in infants and young children. Antimicrob Agents Chemother. 1982 Feb;21(2):248–253. doi: 10.1128/aac.21.2.248. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Seddon M., Wise R., Gillett A. P., Livingston R. Pharmacokinetics of Ro 13-9904, a broad-spectrum cephalosporin. Antimicrob Agents Chemother. 1980 Aug;18(2):240–242. doi: 10.1128/aac.18.2.240. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shaw P. G., Fairley K. F., Whitworth J. A. Treatment of urinary tract infection with a single-dose intramuscular administration of cephamandole. Med J Aust. 1980 May 17;1(10):489–489. doi: 10.5694/j.1326-5377.1980.tb135049.x. [DOI] [PubMed] [Google Scholar]
- Steele R. W., Bradsher R. W. Comparison of ceftriaxone with standard therapy for bacterial meningitis. J Pediatr. 1983 Jul;103(1):138–141. doi: 10.1016/s0022-3476(83)80801-4. [DOI] [PubMed] [Google Scholar]
- Thomas V., Shelokov A., Forland M. Antibody-coated bacteria in the urine and the site of urinary-tract infection. N Engl J Med. 1974 Mar 14;290(11):588–590. doi: 10.1056/NEJM197403142901102. [DOI] [PubMed] [Google Scholar]